Market closedNon-fractional

Silk Road Medical/SILK

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Silk Road Medical

Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.

Ticker

SILK

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Sunnyvale, United States

Employees

474

SILK Metrics

BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$1.37
EPS
1.44
Beta
-
Dividend rate
$1.1B
1.44
11.046
9.451
56.823
56.823
-8.30%
-13.99%
-35.04%
5.68
7.18
7.18
-28.63
23.04%
-8.34%
33.28%
-1.35%

What the Analysts think about SILK

Analyst Ratings

Majority rating from 10 analysts.
Hold

SILK Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-29.13% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$48M
2.54%
Net income
-$14M
8.46%
Profit margin
-29.13%
5.77%

SILK Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.56%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.35
-$0.33
-$0.33
-$0.36
-
Expected
-$0.39
-$0.35
-$0.42
-$0.40
-$0.38
Surprise
-10.23%
-6.40%
-21.66%
-10.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Silk Road Medical stock?

Silk Road Medical (SILK) has a market cap of $1.1B as of July 05, 2024.

What is the P/E ratio for Silk Road Medical stock?

The price to earnings (P/E) ratio for Silk Road Medical (SILK) stock is 0 as of July 05, 2024.

Does Silk Road Medical stock pay dividends?

No, Silk Road Medical (SILK) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Silk Road Medical dividend payment date?

Silk Road Medical (SILK) stock does not pay dividends to its shareholders.

What is the beta indicator for Silk Road Medical?

Silk Road Medical (SILK) has a beta rating of 1.44. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Silk Road Medical stock

Buy or sell Silk Road Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing